A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17-Reference-Cited by-同舟云学术

A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17

Published:2022-02-15 Issue:3 Volume:12 Page:787-800
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Armstrong April W.,Blauvelt Andrew,Mrowietz Ulrich,Strober Bruce,Gisondi Paolo,Merola Joseph F.,Langley Richard G.,Ståhle Mona,Lebwohl Mark,Netea Mihai G.,Nunez Gomez Natalie,Warren Richard B.

Funder

UCB

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

https://link.springer.com/content/pdf/10.1007/s13555-022-00687-0.pdf

Reference70 articles.

1. Polese B, Zhang H, Thurairajah B, King IL. Innate lymphocytes in psoriasis. Front Immunol. 2020. https://doi.org/10.3389/fimmu.2020.00242.

2. Damiani G, Bragazzi NL, Karimkhani Aksut C, et al. The global, regional, and national burden of psoriasis: results and insights from the global burden of disease 2019 study. Front Med (Lausanne). 2021. https://doi.org/10.3389/fmed.2021.743180.

3. Blauvelt A, Chiricozzi A. The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin Rev Allergy Immunol. 2018. https://doi.org/10.1007/s12016-018-8702-3.

4. Prinz I, Sandrock I, Mrowietz U. Interleukin-17 cytokines: effectors and targets in psoriasis—a breakthrough in understanding and treatment. J Exp Med. 2019. https://doi.org/10.1084/jem.20191397.

5. Lønnberg AS, Zachariae C, Skov L. Targeting of interleukin-17 in the treatment of psoriasis. Clin Cosmet Investig Dermatol. 2014. https://doi.org/10.2147/ccid.S67534.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Handlungsempfehlungen bei oraler Candidose unter Biologikatherapie bei Psoriasis – Ergebnisse eines Expertenmeetings;Die Dermatologie;2024-09-03

2. Neue Immunsuppressiva und das Risiko opportunistischer Infektionen;Arthritis und Rheuma;2024-05

3. The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel;Dermatology and Therapy;2024-02

4. Bimekizumab safety in patients with moderate to severe plaque psoriasis: Pooled data from up to three years of treatment in randomized phase 3 trials;British Journal of Dermatology;2023-11-10

5. Risk of candidiasis associated with interleukin-17 inhibitors: implications and management;Mycology;2023-10-20